Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.

[1]  R. Kumar,et al.  Topical Interferon &agr;-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia , 2015, Asia-Pacific journal of ophthalmology.

[2]  Sander Dubovy,et al.  High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology. , 2015, The ocular surface.

[3]  W. Dean,et al.  Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola , 2014, Clinical ophthalmology.

[4]  S. Deng,et al.  Topical Interferon Alpha-2b for Treatment of Noninvasive Ocular Surface Squamous Neoplasia with 360° Limbal Involvement , 2014, Journal of ophthalmic & vision research.

[5]  C. S. Moon,et al.  Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. , 2014, Ophthalmology.

[6]  Stephen J. Vincent,et al.  Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. , 2014, American journal of ophthalmology.

[7]  D. Stone,et al.  Ocular Surface Squamous Neoplasia: A Survey of Changes in the Standard of Care From 2003 to 2012 , 2013, Cornea.

[8]  A. Nanji,et al.  Topical chemotherapy for ocular surface squamous neoplasia , 2013, Current opinion in ophthalmology.

[9]  Sanket U. Shah,et al.  Interferon for Ocular Surface Squamous Neoplasia in 81 Cases: Outcomes Based on the American Joint Committee on Cancer Classification , 2013, Cornea.

[10]  A. Galor,et al.  Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. , 2010, Ophthalmology.

[11]  E. Midena,et al.  Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study , 2010, British Journal of Ophthalmology.

[12]  A. Galor,et al.  Pegylated Interferon Alpha 2b for Treatment of Ocular Surface Squamous Neoplasia: A Pilot Study , 2010, Ocular immunology and inflammation.

[13]  A. Gupta,et al.  Treatment of ocular surface squamous neoplasia with Mitomycin C , 2010, British Journal of Ophthalmology.

[14]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[15]  J. N. Barros,et al.  Long-Term Results of Topical Mitomycin C 0.02% for Primary and Recurrent Conjunctival-Corneal Intraepithelial Neoplasia , 2009, Ophthalmic plastic and reconstructive surgery.

[16]  A. Galor,et al.  Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study , 2009, British Journal of Ophthalmology.

[17]  J. Chodosh,et al.  Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. , 2008, Ophthalmology.

[18]  Graham A. Lee,et al.  Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. , 2006, American journal of ophthalmology.

[19]  K. Colby,et al.  Topical Medical Therapies for Ocular Surface Tumors , 2006, Seminars in ophthalmology.

[20]  J. Chodosh,et al.  Ocular Surface Squamous Neoplasia: A Standard of Care Survey , 2005, Cornea.

[21]  C. Shields,et al.  Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. , 2004, Ophthalmology.

[22]  J. Muecke,et al.  Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia , 2003, The British journal of ophthalmology.

[23]  S. Onal,et al.  Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours , 2003, Eye.

[24]  S. Dimitrakos,et al.  Mitomycin C Therapy for Conjunctival-Corneal Intraepithelial Neoplasia , 2002, Cornea.

[25]  C. Shields,et al.  Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. , 2002, American journal of ophthalmology.

[26]  C. Siganos,et al.  The Intraoperative Use of Mitomycin-C in Excision of Ocular Surface Neoplasia With or Without Limbal Autograft Transplantation , 2002, Cornea.

[27]  R. Yeatts,et al.  5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. , 2000, Ophthalmology.

[28]  P. Boccato,et al.  Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil , 2000, The British journal of ophthalmology.

[29]  Y. Rozenman,et al.  Treatment of Conjunctival Intraepithelial Neoplasia with Topical Drops of Mitomycin C , 2000, Cornea.

[30]  P. Boccato,et al.  Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. , 1997, Archives of ophthalmology.

[31]  J. Sugar,et al.  Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. , 1997, Ophthalmology.

[32]  Y. Tsai,et al.  Successful Treatment of Recurrent Corneal Intraepithelial Neoplasia with Topical Mitomycin C , 1997, Cornea.

[33]  M. Wilson,et al.  Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. , 1997, American journal of ophthalmology.

[34]  R. D. Stulting,et al.  Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. , 1997, American journal of ophthalmology.

[35]  C. Shields,et al.  Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. , 1997, Archives of ophthalmology.

[36]  G. Snibson,et al.  Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. , 1997, Ophthalmology.

[37]  R. Yeatts,et al.  Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. , 1995, Ophthalmology.

[38]  L. Hirst,et al.  Ocular surface squamous neoplasia. , 1995, Survey of ophthalmology.

[39]  J. Frucht-Pery,et al.  Mitomycin C therapy for corneal intraepithelial neoplasia. , 1994, American journal of ophthalmology.

[40]  S. Baron,et al.  The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.

[41]  R. Keizer,et al.  Topical application of 5-Fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid , 1986, Documenta Ophthalmologica.

[42]  D. Goette,et al.  Topical chemotherapy with 5-fluorouracil. A review. , 1981, Journal of the American Academy of Dermatology.

[43]  Martindale.,et al.  THE EXTRA PHARMACOPOEIA , 1937 .

[44]  J. Muecke,et al.  Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy , 2015, Clinical & experimental ophthalmology.

[45]  H. Heimann,et al.  Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experience , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[46]  A. Eggermont,et al.  Redefining the role of interferon in the treatment of malignant diseases. , 2010, European journal of cancer.

[47]  M. M. Ballús,et al.  Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors , 2005 .

[48]  F. Hu,et al.  Interferon treatment for corneolimbal squamous dysplasia. , 1998, American journal of ophthalmology.

[49]  J. Reynolds.  Martindale : the extra pharmacopoeia , 1993 .